vs
Broadstone Net Lease, Inc.（BNL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Broadstone Net Lease, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$121.4M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 38.2%，领先345.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 11.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.1%）
Broadstone Net Lease, Inc.是一家房地产投资信托公司，主要在美国市场收购、持有并管理单一租户商业地产资产组合，覆盖工业设施、医疗物业、零售门店、办公空间等核心板块，所有物业均与租户签订长期净租赁协议。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BNL vs RIGL — 直观对比
营收规模更大
BNL
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出9.5%
11.7%
净利率更高
RIGL
高出345.8%
38.2%
两年增速更快
RIGL
近两年复合增速
7.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $121.4M | $69.8M |
| 净利润 | $46.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 52.2% | 33.2% |
| 净利率 | 38.2% | 384.0% |
| 营收同比 | 11.7% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.24 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNLRIGL
| Q1 26 | $121.4M | — | ||
| Q4 25 | $118.3M | $69.8M | ||
| Q3 25 | $114.2M | $69.5M | ||
| Q2 25 | $113.0M | $101.7M | ||
| Q1 25 | $108.7M | $53.3M | ||
| Q4 24 | $112.1M | $57.6M | ||
| Q3 24 | $108.4M | $55.3M | ||
| Q2 24 | $105.9M | $36.8M |
净利润BNLRIGL
| Q1 26 | $46.4M | — | ||
| Q4 25 | $33.1M | $268.1M | ||
| Q3 25 | $26.5M | $27.9M | ||
| Q2 25 | $20.2M | $59.6M | ||
| Q1 25 | $16.7M | $11.4M | ||
| Q4 24 | $26.4M | $14.3M | ||
| Q3 24 | $35.6M | $12.4M | ||
| Q2 24 | $35.3M | $-1.0M |
毛利率BNLRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率BNLRIGL
| Q1 26 | 52.2% | — | ||
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% |
净利率BNLRIGL
| Q1 26 | 38.2% | — | ||
| Q4 25 | 28.0% | 384.0% | ||
| Q3 25 | 23.2% | 40.2% | ||
| Q2 25 | 17.8% | 58.6% | ||
| Q1 25 | 15.4% | 21.5% | ||
| Q4 24 | 23.5% | 24.9% | ||
| Q3 24 | 32.8% | 22.5% | ||
| Q2 24 | 33.4% | -2.8% |
每股收益（稀释后）BNLRIGL
| Q1 26 | $0.24 | — | ||
| Q4 25 | $0.17 | $14.11 | ||
| Q3 25 | $0.14 | $1.46 | ||
| Q2 25 | $0.10 | $3.28 | ||
| Q1 25 | $0.09 | $0.63 | ||
| Q4 24 | $0.13 | $0.82 | ||
| Q3 24 | $0.19 | $0.70 | ||
| Q2 24 | $0.19 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.3M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $3.0B | $391.5M |
| 总资产 | $5.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BNLRIGL
| Q1 26 | $20.3M | — | ||
| Q4 25 | $30.5M | $155.0M | ||
| Q3 25 | $82.0M | $137.1M | ||
| Q2 25 | $20.8M | $108.4M | ||
| Q1 25 | $9.6M | $77.1M | ||
| Q4 24 | $14.8M | $77.3M | ||
| Q3 24 | $9.0M | $61.1M | ||
| Q2 24 | $18.3M | $49.1M |
总债务BNLRIGL
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $52.5M | ||
| Q3 25 | $2.4B | $60.0M | ||
| Q2 25 | $2.1B | $60.0M | ||
| Q1 25 | $2.0B | $60.0M | ||
| Q4 24 | $1.9B | $60.0M | ||
| Q3 24 | $2.0B | $60.0M | ||
| Q2 24 | $1.9B | $60.0M |
股东权益BNLRIGL
| Q1 26 | $3.0B | — | ||
| Q4 25 | $2.9B | $391.5M | ||
| Q3 25 | $2.9B | $117.6M | ||
| Q2 25 | $2.9B | $81.9M | ||
| Q1 25 | $2.9B | $18.6M | ||
| Q4 24 | $3.0B | $3.3M | ||
| Q3 24 | $3.0B | $-14.6M | ||
| Q2 24 | $3.1B | $-29.9M |
总资产BNLRIGL
| Q1 26 | $5.8B | — | ||
| Q4 25 | $5.7B | $513.6M | ||
| Q3 25 | $5.5B | $242.5M | ||
| Q2 25 | $5.3B | $206.7M | ||
| Q1 25 | $5.2B | $176.0M | ||
| Q4 24 | $5.2B | $164.0M | ||
| Q3 24 | $5.3B | $139.4M | ||
| Q2 24 | $5.3B | $128.4M |
负债/权益比BNLRIGL
| Q1 26 | — | — | ||
| Q4 25 | 0.87× | 0.13× | ||
| Q3 25 | 0.82× | 0.51× | ||
| Q2 25 | 0.73× | 0.73× | ||
| Q1 25 | 0.68× | 3.23× | ||
| Q4 24 | 0.64× | 18.25× | ||
| Q3 24 | 0.65× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BNLRIGL
| Q1 26 | — | — | ||
| Q4 25 | $299.5M | $22.0M | ||
| Q3 25 | $64.2M | $24.0M | ||
| Q2 25 | $79.3M | $30.5M | ||
| Q1 25 | $71.5M | $-893.0K | ||
| Q4 24 | $276.3M | $14.5M | ||
| Q3 24 | $67.3M | $21.7M | ||
| Q2 24 | $74.2M | $302.0K |
自由现金流BNLRIGL
| Q1 26 | — | — | ||
| Q4 25 | $269.8M | — | ||
| Q3 25 | $58.0M | — | ||
| Q2 25 | $76.7M | — | ||
| Q1 25 | $57.1M | — | ||
| Q4 24 | $259.5M | — | ||
| Q3 24 | $60.3M | — | ||
| Q2 24 | $74.0M | — |
自由现金流率BNLRIGL
| Q1 26 | — | — | ||
| Q4 25 | 228.1% | — | ||
| Q3 25 | 50.8% | — | ||
| Q2 25 | 67.9% | — | ||
| Q1 25 | 52.5% | — | ||
| Q4 24 | 231.4% | — | ||
| Q3 24 | 55.6% | — | ||
| Q2 24 | 69.9% | — |
资本支出强度BNLRIGL
| Q1 26 | — | — | ||
| Q4 25 | 25.1% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 13.2% | — | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 0.2% | — |
现金转化率BNLRIGL
| Q1 26 | — | — | ||
| Q4 25 | 9.04× | 0.08× | ||
| Q3 25 | 2.43× | 0.86× | ||
| Q2 25 | 3.93× | 0.51× | ||
| Q1 25 | 4.27× | -0.08× | ||
| Q4 24 | 10.47× | 1.01× | ||
| Q3 24 | 1.89× | 1.75× | ||
| Q2 24 | 2.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
